Exclusive Distribution Part 1: Essential Questions to Ask When Choosing a Model
This first part of our Exclusive Distribution episode kicks off with Donovan Quill, Executive Vice President, Business Development of Growth & Strategy at AscellaHealth and Charlie Gayer, Chief Commercial Officer at BioCryst, discussing the critical factors that influence the decision to adopt an exclusive model of pharmaceutical product distribution; exploring how product characteristics, patient and prescriber profiles, market dynamics, and strategic objectives all play a pivotal role in determining the most suitable distribution strategy.
About AscellaHealth
Healthcare today is more complex than ever—especially when it comes to therapies for people living with rare and chronic conditions. These high-cost, high-impact treatments account for only a small fraction of prescriptions, but they make up the largest and fastest-growing share of total drug spend. As a result, balancing affordability and quality of care remains a significant challenge.
We’re here to change that.
Because at AscellaHealth, we believe that all patients in need should have the ability to access life-changing therapies.
Our Core Beliefs
At AscellaHealth, patients are not just part of the process—they’re why we do what we do. Every solution we build and every partnership we form is designed with the patient in mind.
Patients First, Always.
Balancing Cost and Care.
Better Stakeholder Outcomes.